- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, December 9, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by HealthITAnalytics cited a study pubished in the December 2022 issue of The American Journal of Managed Care® (AJMC®). The study, “On the Impact of Predictive Analytics–Driven Disease Management Interventions,” showed that predictive analytics–driven disease management outperforms standard of care among patients with chronic heart failure.
An article by Wired referenced a study published in a 2016 supplement to AJMC®, titled “Economic Costs of Hemophilia and the Impact of Prophylactic Treatment on Patient Management.” The study indicated that intravenous infusions for the management of hemophilia cost patients an average of $127,194 per year.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
